Objective: To determine the frequency of the various underlying causes of erythroderma in newborns or infants, as well as which clinical or laboratory findings were relevant for the etiological diagnosis.
Patients: Fifty-one patients who presented with exfoliative erythroderma during their first year of life were included in this retrospective study.
Setting: Department of Pediatric Dermatology at a university hospital.
Results: On average, the etiological diagnosis was established 11 months after the onset of erythroderma. The underlying causes observed included immunodeficiency (30%), simple or complex ichthyosis (24%), Netherton syndrome (18%), and eczematous or papulosquamous dermatitis (20%). Five patients (10%) had erythroderma of unknown origin. The following parameters were of value in determining the underlying cause of erythroderma: congenital onset, skin induration and the presence of large scaling plaques, alopecia with or without hair dysplasia, evolution, response to topical corticosteroid therapy, presence of infections, and failure to thrive. Histological analysis confirmed the diagnosis in only 19 (45%) of 42 cases. However, it proved of great value for the detection of significant lymphocyte infiltration or keratinocyte necrosis indicating a diagnosis of Omenn syndrome or immunodeficiency. The prognosis was poor in this series: the mortality rate was 16%, and severe dermatosis persisted in 29 (67%) of the survivors.
Conclusions: The etiological diagnosis of neonatal erythroderma is difficult to make; some clinical features may be helpful, but no one feature is characteristic of a cause. An immunodeficiency must be suspected in cases of severe erythroderma with skin induration, severe alopecia, failure to thrive, infectious complications, or evocative histological findings. The prognosis is poor, with a high rate of mortality in immunodeficiency disorders and severe chronic disease in Netherton syndrome and psoriasis.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1001/archderm.136.7.875 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Cytokine Profiling of Erythroderma Biopsies Reveals Types 2 and 17 Immune Activation Status.
J Cutan Pathol
December 2024
Department of Dermatology and Pathology, University of California, California, USA.
Background: Erythroderma is a dermatologic condition characterized by widespread red and scaly skin. The causes include, but are not limited to, psoriasis, eczema, drug eruptions, pityriasis rubra pilaris (PRP), and cutaneous T-cell lymphoma. Most of these are typified by Type 2 (e.
View Article and Find Full Text PDFErythroderma in the elderly.
J Dermatol
November 2024
Department of Dermatology, Fukushima Medical University, Fukushima, Japan.
Erythroderma is the end-stage condition caused by various inflammatory diseases, presenting with widespread generalized coalesced erythema on the trunk and extremities. Erythroderma is not a disease itself, but rather is a symptom expressing erythrodermic condition, which is frequently associated with inguinal lymphadenopathy, chills, and mild fever. The clinical characteristics include sparing the folds of the trunk and extremities (deck-chair sign), and cobblestone-like disseminated grouping prurigo; however, the deck-chair sign is not specific to papulo-erythroderma (Ofuji disease).
View Article and Find Full Text PDFA case of peeling skin syndrome type 1 with novel CDSN gene variation successfully treated with upadacitinib.
J Dermatol
October 2024
Department of Dermatology, West China Hospital, Sichuan University, Chengdu, China.
Peeling skin syndrome type 1 (PSS1) is an autosomal recessive genodermatosis caused by the CDSN gene loss-of-function mutation and characterized by widespread superficial skin peeling and erythroderma with unbearable pruritus. Because of its ultra-rarity and unclear mechanism, this rare disease has no established treatment regimen. Herein, we reported a Chinese woman who presented with congenital generalized pruritic erythroderma and exfoliation, notable for significantly elevated IgE levels.
View Article and Find Full Text PDFDeciphering the Etiologies of Adult Erythroderma: An Updated Guide to Presentations, Diagnostic Tools, Pathophysiologies, and Treatments.
Am J Clin Dermatol
November 2024
Department of Dermatology, Northwestern University Feinberg School of Medicine, 676 N Saint Clair, Arkes 1600, Chicago, IL, 60611, USA.
Article Synopsis
- Erythroderma is a serious inflammatory skin condition known for widespread redness and can include symptoms like peeling, pus formation, and blisters, often leading to significant health risks.
- Identifying the root cause of erythroderma can be difficult, which complicates treatment and contributes to a generally poor outlook for affected individuals.
- The review outlines the appearance, causes, diagnosis, and treatment options for erythroderma, and highlights the differences between similar skin conditions, along with new research aimed at improving future diagnosis and care.
A novel MALT1 variant in an Egyptian patient presenting with exfoliative dermatitis: a case-based review.
Immunol Res
October 2024
Department of Pediatrics, Faculty of Medicine, Cairo University, Cairo, Egypt.
Article Synopsis
- Recent studies show that errors in the CARD11-BCL10-MALT1 (CBM) signalosome can cause severe immunodeficiencies, presenting with various symptoms including frequent infections and skin issues.
- A case study of an Egyptian patient with a mutation in the MALT1 gene revealed severe skin rashes, diarrhea, pneumonia, and abnormal immune markers, indicating a diagnosis of immunodeficiency-12 (IMD12).
- The research emphasizes the importance of molecular diagnosis to differentiate between similar immunodeficiencies, as better understanding can facilitate early treatment options like stem cell transplantation, improving patient outcomes.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!